PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Drug or technology

Metal Nanoparticles

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUL 24, 2026 · JOURNAL ARTICLE

Efficiency of nanovaccines compared with antibiotic therapy in the prevention and immunomodulation of listeriosis.

Emerging Microbes & Infections

Early-phase preclinical and translational work comparing nanovaccines to antibiotics in mouse models of neonatal listeriosis and in vitro dendritic cell immunomodulation; lacks clinical trial data and human efficacy endpoints.

PreliminaryGold Glyconanoparticles Vicente Soriano Nanovaccines

Reported

In-hospital mortality rate in adu…increased twofold

Highest proportion of hospitalize…96.5%

Case fatality rate in elderly ind…17%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support